The effect of sertindole on QTD and TPTE

Acta Psychiatrica Scandinavica

Volumn 121, Issue 5, 2010, Pages 385-388

  Nielsen, J ^a   Andersen, M P ^b   Graff, C ^b   Kanters, J K ^c,d   Hardahl, T ^b   Dybbro, J ^e   Struijk, J J ^b   Meyer, J M ^f   Toft, E ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

QT dispersion; QTc; Sertindole; Sudden death; Torsade de pointes; Tpeak Tend

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE MARKER; DRUG EFFECT; DRUG EXPOSURE; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; QT PROLONGATION; SCHIZOPHRENIA; SIDE EFFECT; T WAVE; TORSADE DES POINTES;

ADULT; ANTIPSYCHOTIC AGENTS; DENMARK; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; IMIDAZOLES; INDOLES; LONG QT SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SAFETY-BASED DRUG WITHDRAWALS; SCHIZOPHRENIA; SIGNAL PROCESSING, COMPUTER-ASSISTED; TORSADES DE POINTES;

EID: 77950929074     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01534.x     Document Type: Article

References (15)

1. Molnar J, Somberg JC. QT dispersion: still a useful measurement. Cardiology 2009 112 : 165 167.
2. Shah RR. Drug-induced QT dispersion: does it predict the risk of torsade de pointes? J Electrocardiol 2005 38 : 10 18.
3. Hohnloser SH. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. Am J Cardiol 1997 80 : 82G 89G.
4. Savelieva I, Yap YG, Yi G, Guo X, Camm AJ, Malik M. Comparative reproducibility of QT, QT peak, and T peak-T end intervals and dispersion in normal subjects, patients with myocardial infarction, and patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1998 21 : 2376 2381.
5. Couderc JP, Kaab S, Hinterseer M et al. Investigating the role of ventricular repolarization morphology in surface Ecgs for identifying patients with a history of drug-induced arrhythmias. Comput Cardiol 2007 34 : 337 350.
6. Pezawas L, Quiner S, Moertl D et al. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance. Int Clin Psychopharmacol 2000 15 : 207 214.
7. Moore N, Hall G, Sturkenboom M, Mann R, Lagnaoui R, Begaud B. Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole. Pharmacoepidemiol Drug Saf 2003 12 : 271 281.
8. Peuskens J, Moore N, Azorin JM, Toumi M, Cochran J. The European sertindole safety and exposure survey: a follow-up study of 8600 patients. Pharmacoepidemiol Drug Saf 2007 16 : 804 811.
9. Wehnert A. The European Post-marketing Observational Serdolect (EPOS) Project: increasing our understanding of schizophrenia therapy. Int Clin Psychopharmacol 1998 13 (Suppl. 3 S27 S30.
10. Wilton LV, Heeley EL, Pickering RM, Shakir SA. Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine. J Psychopharmacol 2001 15 : 120 126.
11. Kors JA, Van Herpen G. Measurement error as a source of QT dispersion: a computerised analysis. Heart 1998 80 : 453 458.
12. Yerrabolu M, Prabhudesai S, Tawam M, Winter L, Kamalesh M. Effect of risperidone on QT interval and QT dispersion in the elderly. Heart Dis 2000 2 : 10 12.
13. Tisdale JE, Rasty S, Padhi ID, Sharma ND, Rosman H. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes. J Clin Pharmacol 2001 41 : 1310 1318.
14. Haverkamp W, Eckhardt L, Matz J, Frederiksen K. Sertindole: cardiac electrophysiological profile. Int J Psychiatry 2002 6 : 11 20.
15. Nielsen J, Graff C, Hardahl T et al. Sertindole causes distinct electrocardiographic T-wave morphology changes. Eur Neuropsychopharmacol 2009 19 : 702 707.